XBI vs. KWEB
XBI (SPDR S&P Biotech ETF) and KWEB (KraneShares CSI China Internet ETF) are both exchange-traded funds - XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while KWEB is a China Equities fund tracking the CSI Overseas China Internet Index. Both are passively managed. Over the past 10 years, XBI returned 11.96%/yr vs -0.63%/yr for KWEB. At a 0.42 correlation, their price movements are largely independent. XBI charges 0.35%/yr vs 0.70%/yr for KWEB.
Performance
XBI vs. KWEB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBI achieves a 24.45% return, which is significantly higher than KWEB's -30.60% return. Over the past 10 years, XBI has outperformed KWEB with an annualized return of 11.96%, while KWEB has yielded a comparatively lower -0.63% annualized return.
XBI
- 1D
- 1.26%
- 1M
- 13.79%
- YTD
- 24.45%
- 6M
- 20.14%
- 1Y
- 82.88%
- 3Y*
- 22.41%
- 5Y*
- 1.92%
- 10Y*
- 11.96%
KWEB
- 1D
- -2.76%
- 1M
- -13.32%
- YTD
- -30.60%
- 6M
- -31.53%
- 1Y
- -27.19%
- 3Y*
- -0.64%
- 5Y*
- -16.73%
- 10Y*
- -0.63%
XBI vs. KWEB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBI SPDR S&P Biotech ETF | 24.45% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
KWEB KraneShares CSI China Internet ETF | -30.60% | 23.55% | 12.01% | -9.06% | -17.24% | -49.01% | 58.23% | 29.92% | -33.80% | 69.73% |
Correlation
The correlation between XBI and KWEB is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Aug 1, 2013 | 0.42 |
The correlation between XBI and KWEB shifts across timeframes, from 0.25 (1 year) to 0.42 (all time), reflecting how their relationship changes across market environments.
XBI vs. KWEB - Sectors Allocation Comparison
Sectors
XBI
KWEB
Healthcare
Financial Services
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
-
Healthcare
XBI
KWEB
Financial Services
XBI
KWEB
Basic Materials
XBI
KWEB
-
Communication Services
XBI
-
KWEB
Consumer Cyclical
XBI
-
KWEB
Consumer Defensive
XBI
-
KWEB
Energy
XBI
-
KWEB
-
Industrials
XBI
-
KWEB
Real Estate
XBI
-
KWEB
Technology
XBI
-
KWEB
Utilities
XBI
-
KWEB
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBI vs. KWEB — Risk / Return Rank
XBI
KWEB
XBI vs. KWEB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and KraneShares CSI China Internet ETF (KWEB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XBI | KWEB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.15 | ||
| Sortino ratioReturn per unit of downside risk | +5.44 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 0.84 | +0.64 |
| Calmar ratioReturn relative to maximum drawdown | 8.57 | -0.66 | +9.23 |
| Martin ratioReturn relative to average drawdown | 25.32 | -1.43 | +26.75 |
Loading charts...
Drawdowns
XBI vs. KWEB - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, smaller than the maximum KWEB drawdown of -80.92%. Use the drawdown chart below to compare losses from any high point for XBI and KWEB.
Loading charts...
Drawdown Indicators
| XBI | KWEB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.89% | -80.92% | +17.03% |
Max Drawdown (1Y)Largest decline over 1 year | -9.72% | -41.62% | +31.90% |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | -41.62% | +8.63% |
Max Drawdown (5Y)Largest decline over 5 years | -54.71% | -72.17% | +17.46% |
Max Drawdown (10Y)Largest decline over 10 years | -63.89% | -80.92% | +17.03% |
Current DrawdownCurrent decline from peak | -12.30% | -72.67% | +60.37% |
Average DrawdownAverage peak-to-trough decline | -20.93% | -35.39% | +14.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.28% | 19.04% | -15.76% |
Volatility
XBI vs. KWEB - Volatility Comparison
SPDR S&P Biotech ETF (XBI) has a higher volatility of 9.94% compared to KraneShares CSI China Internet ETF (KWEB) at 8.14%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than KWEB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBI | KWEB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.94% | 8.14% | +1.80% |
Volatility (6M)Calculated over the trailing 6-month period | 21.13% | 20.56% | +0.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.48% | 27.10% | -0.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.30% | 47.70% | -15.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.00% | 40.00% | -8.00% |
XBI vs. KWEB - Expense Ratio Comparison
XBI has a 0.35% expense ratio, which is lower than KWEB's 0.70% expense ratio.
Dividends
XBI vs. KWEB - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.38%, less than KWEB's 8.87% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KWEB KraneShares CSI China Internet ETF | 8.87% | 6.16% | 3.51% | 1.71% | 0.00% | 7.07% | 0.29% | 0.08% | 3.40% | 0.58% | 1.19% | 0.46% |
XBI SPDR S&P Biotech ETF | 0.38% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
XBI and KWEB have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (9.94%) compared to KWEB (8.14%). In terms of maximum drawdown, XBI dropped -63.89% vs KWEB's -80.92%.
On 10-year performance, XBI leads with 11.96% vs -0.63% for KWEB. On fees, XBI is cheaper at 0.35% per year. On volatility, KWEB has been the lower-risk option at 8.14%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XBI has performed better with a 11.96% return vs -0.63%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XBI is cheaper with a 0.35% expense ratio, compared with 0.70% for KWEB.
KWEB has the higher dividend yield at 8.87%, compared with 0.38% for XBI.
XBI is categorized as Health & Biotech Equities, while KWEB is China Equities. XBI tracks S&P Biotechnology Select Industry Index, while KWEB tracks CSI Overseas China Internet Index. They also come from different issuers: State Street and KraneShares. Their fees differ too: 0.35% for XBI and 0.70% for KWEB.
XBI currently has the higher Sharpe Ratio (3.15 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBI and KWEB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer